Multifunctional nanoparticles have the potential to deliver both therapeutics and diagnostics to tissues simultaneously using a single nanodevice. To date, several types of hybrid nanosystems have been developed and used in vitro for magnetic cell separation and targeting. However, the in vivo utility of these nanocomposites may be limited due to poor stability or short systemic circulation times. Furthermore, existing technologies do not adequately allow for co-delivery of a therapeutic and an agent enabling advanced diagnostic imaging.
This invention provides both the composition and a novel method for creating micellar hybrid nanoparticles that exhibit substantial in vivo circulation times, allowing them to contain a diverse payload for periods of time sufficient for delivery and subsequent release to a desired tissue. In addition, this technology readily facilitates the simultaneous targeted delivery of both therapeutic and imaging agents to diseased tissue in vitro or in vivo.
This technology is offered exclusively or nonexclusively for U.S. and/or worldwide territories. A commercial sponsor for potential future research is sought.
This technology has been used in vitro and in vivo to deliver an anti-cancer agent and two types of nanoparticles that aid in fluorescence and magnetic resonance imaging to diseased tissue (see reference below).
drug delivery, biological imaging, cancer, diagnostics, nanotechnology, nanoparticles, micelle